This slowing contributes to the appetite suppression that drives weight loss and the postprandial glucose-lowering effect, and it also drives most of the gastrointestinal side effect profile.[1],[2] A 2025 review in the Journal of Clinical Endocrinology & Metabolism summarizes the published evidence: GLP-1 receptor agonists impact gastric, intestinal, and gallbladder motility simultaneously, with effects on gastric fundus relaxation, antral contractility inhibition, increased pyloric tone, and reduced small intestinal motility.[3] The path from this mechanism to constipation is straightforward
Qty: 200gr pure powder Directions and Dosage: Take 1/8 teaspoon once or twice daily with food
C th iu tr bnh trm cm Mt nghin cu trn 136 ngi ln tui pht hin ra rng s dng Ginkgo Biloba dng chit xut c th ci thin cc triu chng trm cm v lm gim i mc S100B ( y l mt du hiu ca chn thng no, khi kt hp vi cc dng thuc chng trm cm)
Obesity, visceral fat and Crohns disease
Novo Nordisk which manufactures the drugs has asked doctors in the US to stop starting new patients on the drugs following 'unprecedented product demand and short-term manufacturing issues'